Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
T2GO is a clinical research study that is being done to find out more about how the study drug, called dapagliflozin, works in young people aged 10–24 years who have Type 2 Diabetes. This app will help guide you as you participate in the study.
